Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

NCT00106561 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Kidney Disease
Diabetic Nephropathy
Glomerulonephritis
Proteinuria

Interventions

DRUG: Spironolactone
DRUG: Irbesartan

Sponsor

Melbourne Health